Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof

Details for Australian Patent Application No. 2011212929 (hide)

Owner Biomarin Pharmaceutical Inc.

Inventors Okhamafe, Augustus O.; Bell, Sean M.; Zecherle, G. Nick; Antonsen, Kris; Zhang, Yanhong; Ly, Kieu Y; Fitzpatrick, Paul A.; Kakkis, Emil D.; Vellard, Michel Claude; Wendt, Daniel J.; Muthalif, Mubarack

Agent HENRY HUGHES LIMITED

Pub. Number AU-A-2011212929

PCT Pub. Number WO2011/097335

Priority 61/301,478 04.02.10 US

Filing date 3 February 2011

Wipo publication date 11 August 2011

International Classifications

C07K 1/00 General processes for the preparation of peptides

A61K 38/51 Medicinal preparations containing peptides

Event Publications

21 June 2012 PCT application entered the National Phase

  PCT publication WO2011/097335 Priority application(s): WO2011/097335

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011212930-Highly selective 5-HT(2C) receptor agonists having antagonist activity at the 5-HT(2B) receptor

2011212928-Dihydropyridophthalazinone inhibitors of poly(ADP-ribose) polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency